Organon has announced the acquisition from Biogen of US regulatory and commercial rights for intravenous infusion of ...

Plans outlined by HHS Secretary Robert F Kennedy, Jr look set to target jobs at the US Department of Health & Human Services ...

The Series B funds will support the launch of a Phase I/II clinical trial for AIR-001 to advance its RNA editing pipeline.

Amneal Pharmaceuticals and Shilpa Medicare have launched the new presentation of bortezomib, Boruzu, for subcutaneous or ...

Apellis Pharmaceuticals has announced US FDA acceptance of the sNDA and the granting of priority review status to Empaveli ...

Is 'nearshoring', the preference among pharma and biotech to move operations to the domestic markets versus outsourcing ...

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround ...

EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.

A federal judge in Houston has rejected the third attempt by J&J subsidiary Red River to settle lawsuits related to its ...

US-based Johnson & Johnson (J&J) has announced that it will be investing $55bn in new US manufacturing facilities over the ...

But while platform trials have the potential to be more effective and less expensive than traditional trials, challenges ...

BioVersys has announced the grant of key patent claims in China for the BV100 technology, the intravenous formulation of rifabutin.